The Company is a Korea-based company mainly engaged in the genomic analysis. The Company is involved in conducting of genomic analysis using microarrays and next generation sequencing analysis. In addition, the Company is conducting clinical trials for molecular diagnostic products. Molecular diagnostic products include cancer molecular diagnostic products and molecular genetic diagnostic products. Cancer molecular diagnostic products include molecular diagnostic products for colorectal cancer, bladder cancer, lung cancer, stomach cancer, cervical cancer. Molecular genetic diagnostic products include epidermal growth factor receptor (EGFR) mutation diagnosis, as well as human papilloma virus (HPV) diagnostic products. The Company was established on October 06, 2000. The Company share was listed on the Korea Securities Dealers Automated Quotation System ( KOSDAQ ) on March 27, 2019.
Headquarters
44-6, Techno 10-Ro, Yuseong-Gu, Daejeon
Daejeon; Daejeon;
Contact Details: Purchase the Genomictree, Inc. report to view the information.
Website: http://genomictree.com/ko
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service